EMEA-001070-PIP01-10-M02
Key facts
| Active substance |
2-iminobiotin
|
| Therapeutic area |
Neonatology-Paediatric Intensive Care
|
| Decision number |
P/0192/2020
|
| PIP number |
EMEA-001070-PIP01-10-M02
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Treatment of perinatal asphyxia
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Neurophyxia BV
E-mail: info@neurophyxia.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|